In Reply to the Letter to the Editor Regarding "18F-DOPA PET in Medulloblastoma: Two Case Reports".

[1]  G. Spinelli,et al.  Letter to the Editor Regarding "18F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports". , 2021, World neurosurgery.

[2]  A. Bozzao,et al.  Metabolic Evolution of Brain Metastasis After Stereotactic Radiosurgery: Mismatch Between F-DOPA and FDG PET. , 2020, Clinical nuclear medicine.

[3]  J. Pouysségur,et al.  Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma , 2019, Journal of cellular and molecular medicine.

[4]  G. Minniti,et al.  The mean striatal 18F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Ian Law,et al.  Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  M. Mamede,et al.  18F-DOPA uptake parameters in glioma: effects of patients' characteristics and prior treatment history. , 2018, The British journal of radiology.

[7]  John O. Prior,et al.  Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma , 2017, Brain Tumor Pathology.

[8]  N. Albert,et al.  Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment? , 2017, EJNMMI Research.

[9]  K. Langen,et al.  (18)F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports. , 2016, World neurosurgery.